MEI Pharma Inc (MEIP)
2.870
+0.05
(+1.77%)
USD |
NASDAQ |
Jun 20, 16:00
2.80
-0.07
(-2.44%)
After-Hours: 20:00
MEI Pharma Free Cash Flow: -43.82M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -43.82M |
| December 31, 2023 | -53.02M |
| September 30, 2023 | -56.16M |
| June 30, 2023 | -52.52M |
| March 31, 2023 | -56.99M |
| December 31, 2022 | -61.93M |
| September 30, 2022 | -56.34M |
| June 30, 2022 | -49.22M |
| March 31, 2022 | -44.68M |
| December 31, 2021 | -43.26M |
| September 30, 2021 | -30.65M |
| June 30, 2021 | -32.67M |
| March 31, 2021 | 47.60M |
| December 31, 2020 | 52.17M |
| September 30, 2020 | 37.69M |
| June 30, 2020 | 33.36M |
| March 31, 2020 | -43.71M |
| December 31, 2019 | -44.02M |
| September 30, 2019 | -30.90M |
| June 30, 2019 | -29.64M |
| March 31, 2019 | -25.05M |
| December 31, 2018 | -19.91M |
| September 30, 2018 | -27.29M |
| June 30, 2018 | -21.04M |
| March 31, 2018 | -20.75M |
| Date | Value |
|---|---|
| December 31, 2017 | -12.90M |
| September 30, 2017 | -11.90M |
| June 30, 2017 | 3.435M |
| March 31, 2017 | 3.146M |
| December 31, 2016 | -2.848M |
| September 30, 2016 | -3.329M |
| June 30, 2016 | -17.86M |
| March 31, 2016 | -21.12M |
| December 31, 2015 | -24.88M |
| September 30, 2015 | -27.11M |
| June 30, 2015 | -28.08M |
| March 31, 2015 | -27.22M |
| December 31, 2014 | -24.16M |
| September 30, 2014 | -22.16M |
| June 30, 2014 | -19.50M |
| March 31, 2014 | -16.40M |
| December 31, 2013 | -13.97M |
| September 30, 2013 | -11.66M |
| June 30, 2013 | -10.08M |
| March 31, 2013 | -8.61M |
| December 31, 2012 | -8.228M |
| September 30, 2012 | -7.84M |
| June 30, 2012 | -7.081M |
| March 31, 2012 | -7.411M |
| December 31, 2011 | -6.849M |
Free Cash Flow Range, Past 5 Years
-61.93M
Minimum
Dec 2022
52.17M
Maximum
Dec 2020
-27.94M
Average
-43.77M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.928M |
| Cash from Investing (Quarterly) | 0.122M |
| Free Cash Flow Per Share (Quarterly) | -0.4394 |
| Free Cash Flow Yield | -234.9% |